By: M.C. Vekemans MD
What are the challenges the MDS community faces in 2025? Progress has been made in understanding the biology, genetics and pathogenesis of MDS. Prognostication and treatment strategies have been improved, but not satisfactorily. However, so far, many questions remain unanswered.
(BELG J HEMATOL 2025;16(1):23–8)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
